Form 4: McKesson Corp CEO Brian Tyler Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
McKesson Corporation CEO Brian S. Tyler sold 3,753 shares of common stock on September 5, 2024, at a price of $561.1 per share, according to a Form 4 filing with the SEC.
Summary
- Brian S. Tyler, CEO of McKesson Corp, reported a transaction involving the sale of company stock.
- On September 5, 2024, Tyler sold 3,753 shares of common stock at a price of $561.1 per share.
- Following the transaction, Tyler directly owns 78,586 shares of McKesson Corp common stock.
- Tyler also indirectly owns 214.7468 shares through the McKesson Corporation 401(k) Retirement Savings Plan.
- The sale was executed under a pre-arranged trading plan (Rule 10b5-1(c)) adopted on December 2, 2022.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged 10b5-1 plan and doesn't necessarily indicate a change in the executive's outlook on the company.
Industry Context
Executive stock sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information. Investors often monitor these transactions for insights into management's perspective on the company's valuation and future prospects. However, sales under 10b5-1 plans are generally pre-scheduled and may not reflect a change in sentiment.
Comparison to Industry Standards
- Executive compensation practices, including stock sales, are closely watched in the healthcare industry.
- Companies like CVS Health, UnitedHealth Group, and Cigna are often compared to McKesson in terms of executive compensation and insider trading activity.
- The use of 10b5-1 plans is a standard practice among executives at publicly traded companies to avoid accusations of insider trading.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although sales under 10b5-1 plans are usually factored into market expectations.
- The transaction does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2022-12-02 | Date of adoption of the Rule 10b5-1(c) plan |
| 2024-09-05 | Date of the stock sale transaction |
| 2024-09-06 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.